Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 22.22 USD -2.42% Market Closed
Market Cap: 2B USD
Have any thoughts about
Myriad Genetics Inc?
Write Note

Myriad Genetics Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Myriad Genetics Inc
Accumulated Depreciation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Myriad Genetics Inc
NASDAQ:MYGN
Accumulated Depreciation
-$115.1m
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
-6%
Abbvie Inc
NYSE:ABBV
Accumulated Depreciation
-$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Myriad Genetics Inc's Accumulated Depreciation?
Accumulated Depreciation
-115.1m USD

Based on the financial report for Jun 30, 2024, Myriad Genetics Inc's Accumulated Depreciation amounts to -115.1m USD.

What is Myriad Genetics Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-6%

Over the last year, the Accumulated Depreciation growth was 0%. The average annual Accumulated Depreciation growth rates for Myriad Genetics Inc have been -4% over the past three years , -1% over the past five years , and -6% over the past ten years .

Back to Top